Trial intelligence / Profile preview

Goal-directed intraoperative fluid therapy in proximal femoral fracture surgery

2009-018087-10Phase 4Active

Sponsor
Karolinska University Hospital
Start
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ringer's acetate and glucose in hip fracture (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: 30-day all-cause mortality. Started Dec 2009; status: active.

02

Drugs

ringer's acetateglucose
03

Conditions

hip fracture

Beyond the preview

Go deeper on 2009-018087-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-018087-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call